Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2534368rdf:typepubmed:Citationlld:pubmed
pubmed-article:2534368lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2534368lifeskim:mentionsumls-concept:C0022939lld:lifeskim
pubmed-article:2534368lifeskim:mentionsumls-concept:C0314974lld:lifeskim
pubmed-article:2534368lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:2534368pubmed:issue6lld:pubmed
pubmed-article:2534368pubmed:dateCreated1990-5-21lld:pubmed
pubmed-article:2534368pubmed:abstractTextThirty-five patients with alcohol cirrhosis were treated for several months (average 4 months) with Infloran (6 capsules daily). Thirty cirrhotics were treated for the same length of time with lactulose and diuretics. Infloran-treated patients showed reduced ammonium levels, improvement of mental status and psychological performance. In addition, patients who required hospitalization had shorter in-patient periods thanks to a more rapid psychological and physical improvement. Infloran may be considered a valid alternative to conventional therapy for the out-patient management of subjects with alcoholic cirrhosis.lld:pubmed
pubmed-article:2534368pubmed:languageitalld:pubmed
pubmed-article:2534368pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2534368pubmed:citationSubsetIMlld:pubmed
pubmed-article:2534368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2534368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2534368pubmed:statusMEDLINElld:pubmed
pubmed-article:2534368pubmed:monthDeclld:pubmed
pubmed-article:2534368pubmed:issn0009-9074lld:pubmed
pubmed-article:2534368pubmed:authorpubmed-author:ColleRRlld:pubmed
pubmed-article:2534368pubmed:authorpubmed-author:CeschiaTTlld:pubmed
pubmed-article:2534368pubmed:issnTypePrintlld:pubmed
pubmed-article:2534368pubmed:day31lld:pubmed
pubmed-article:2534368pubmed:volume131lld:pubmed
pubmed-article:2534368pubmed:ownerNLMlld:pubmed
pubmed-article:2534368pubmed:authorsCompleteYlld:pubmed
pubmed-article:2534368pubmed:pagination397-402lld:pubmed
pubmed-article:2534368pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:meshHeadingpubmed-meshheading:2534368-...lld:pubmed
pubmed-article:2534368pubmed:year1989lld:pubmed
pubmed-article:2534368pubmed:articleTitle[Oral bacteriotherapy with Bifidobacterium bifidum and Lactobacillus acidophilus in cirrhotic patients].lld:pubmed
pubmed-article:2534368pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2534368pubmed:publicationTypeEnglish Abstractlld:pubmed